Krsnaa Diagnostics Limited (BOM:543328)
611.25
-13.30 (-2.13%)
At close: Apr 21, 2026
Krsnaa Diagnostics Revenue
Krsnaa Diagnostics had revenue of 1.81B INR in the quarter ending December 31, 2025, with 3.83% growth. This brings the company's revenue in the last twelve months to 7.66B, up 9.88% year-over-year. In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B with 15.74% growth.
Revenue (ttm)
7.66B
Revenue Growth
+9.88%
P/S Ratio
2.56
Revenue / Employee
2.21M
Employees
3,471
Market Cap
19.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.17B | 975.27M | 15.74% |
| Mar 31, 2024 | 6.20B | 1.33B | 27.20% |
| Mar 31, 2023 | 4.87B | 316.73M | 6.95% |
| Mar 31, 2022 | 4.55B | 589.94M | 14.88% |
| Mar 31, 2021 | 3.96B | 1.38B | 53.41% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 7.92B |
| One Global Service Provider | 4.45B |
| Chandan Healthcare | 2.65B |
| Star Imaging and Path Lab | 860.99M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 301.81M |
| Aspira Pathlab & Diagnostics | 242.36M |
| Clinitech Laboratory | 92.39M |
Krsnaa Diagnostics News
- 2 months ago - Why are Krsnaa Diagnostics shares down 3% today? Explained - Business Upturn
- 4 months ago - Krsnaa Diagnostics approves Rs 430 crore fundraise via NCDs - Business Upturn
- 5 months ago - Krsnaa Diagnostics shares jump over 3% as Q2 revenue rises 10.5% YoY to Rs 206 crore, net profit rose 21.9% - Business Upturn
- 9 months ago - Krsnaa Diagnostics shares fall over 3% following Q1 results - Business Upturn
- 10 months ago - Krsnaa Diagnostics gets Rajasthan High Court nod, to proceed with NHM lab services contract - Business Upturn
- 1 year ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 1 year ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 1 year ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn